Form 4: Myriad Genetics Executive Sells Shares to Cover Tax Obligations
SEC Form 4
Mark Verratti, Chief Commercial Officer of Myriad Genetics, sold 1,075 shares to cover tax obligations related to vesting restricted stock units.
Summary
- On September 21, 2024, Mark Verratti, the Chief Commercial Officer of Myriad Genetics, sold 1,075 shares of common stock.
- The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units.
- The price per share was $27.64.
- Following the transaction, Verratti directly owns 297,640 shares of Myriad Genetics.
- The sale was reported on September 23, 2024.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes) and doesn't indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations related to stock-based compensation.
Key Dates
| Date | Description |
|---|---|
| 09/20/2024 | Date used to determine the closing price of Myriad common stock for tax withholding. |
| 09/21/2024 | Date of the transaction (stock sale). |
| 09/23/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.